315 related articles for article (PubMed ID: 25379355)
1. Roles of c-FLIP in Apoptosis, Necroptosis, and Autophagy.
Safa AR
J Carcinog Mutagen; 2013; Suppl 6():. PubMed ID: 25379355
[TBL] [Abstract][Full Text] [Related]
2. c-FLIP, a master anti-apoptotic regulator.
Safa AR
Exp Oncol; 2012 Oct; 34(3):176-84. PubMed ID: 23070002
[TBL] [Abstract][Full Text] [Related]
3. Targeting the Anti-Apoptotic Protein c-FLIP for Cancer Therapy.
Safa AR; Pollok KE
Cancers (Basel); 2011 Jun; 3(2):1639-71. PubMed ID: 22348197
[TBL] [Abstract][Full Text] [Related]
4. A role for c-FLIP(L) in the regulation of apoptosis, autophagy, and necroptosis in T lymphocytes.
He MX; He YW
Cell Death Differ; 2013 Feb; 20(2):188-97. PubMed ID: 23175183
[TBL] [Abstract][Full Text] [Related]
5. FLIP as a therapeutic target in cancer.
Humphreys L; Espona-Fiedler M; Longley DB
FEBS J; 2018 Nov; 285(22):4104-4123. PubMed ID: 29806737
[TBL] [Abstract][Full Text] [Related]
6. Differential responses of FLIPLong and FLIPShort-overexpressing human myeloid leukemia cells to TNF-alpha and TRAIL-initiated apoptotic signals.
Seal S; Hockenbery DM; Spaulding EY; Kiem HP; Abbassi N; Deeg HJ
Exp Hematol; 2008 Dec; 36(12):1660-72. PubMed ID: 18838202
[TBL] [Abstract][Full Text] [Related]
7. c-FLIP, a Novel Biomarker for Cancer Prognosis, Immunosuppression, Alzheimer's Disease, Chronic Obstructive Pulmonary Disease (COPD), and a Rationale Therapeutic Target.
Safa AR; Kamocki K; Saadatzadeh MR; Bijangi-Vishehsaraei K
Biomark J; 2019; 5(1):. PubMed ID: 32352084
[TBL] [Abstract][Full Text] [Related]
8. ITCH-dependent proteasomal degradation of c-FLIP induced by the anti-HER3 antibody 9F7-F11 promotes DR5/caspase 8-mediated apoptosis of tumor cells.
Le Clorennec C; Lazrek Y; Dubreuil O; Sampaio C; Larbouret C; Lanotte R; Poul MA; Barret JM; Prost JF; Pèlegrin A; Chardès T
Cell Commun Signal; 2019 Aug; 17(1):106. PubMed ID: 31443721
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of intracellular anti-apoptotic proteins, particularly c-FLIP by therapeutic agents; the novel view to overcome resistance to TRAIL.
Hassanzadeh A; Farshdousti Hagh M; Alivand MR; Akbari AAM; Shams Asenjan K; Saraei R; Solali S
J Cell Physiol; 2018 Oct; 233(10):6470-6485. PubMed ID: 29741767
[TBL] [Abstract][Full Text] [Related]
10. Crosstalk between apoptosis, necrosis and autophagy.
Nikoletopoulou V; Markaki M; Palikaras K; Tavernarakis N
Biochim Biophys Acta; 2013 Dec; 1833(12):3448-3459. PubMed ID: 23770045
[TBL] [Abstract][Full Text] [Related]
11. Synergistic anticancer effect of cisplatin and Chal-24 combination through IAP and c-FLIPL degradation, Ripoptosome formation and autophagy-mediated apoptosis.
Shi S; Wang Q; Xu J; Jang JH; Padilla MT; Nyunoya T; Xing C; Zhang L; Lin Y
Oncotarget; 2015 Jan; 6(3):1640-51. PubMed ID: 25682199
[TBL] [Abstract][Full Text] [Related]
12. c-FLIP knockdown induces ligand-independent DR5-, FADD-, caspase-8-, and caspase-9-dependent apoptosis in breast cancer cells.
Day TW; Huang S; Safa AR
Biochem Pharmacol; 2008 Dec; 76(12):1694-704. PubMed ID: 18840411
[TBL] [Abstract][Full Text] [Related]
13. ERK controls epithelial cell death receptor signalling and cellular FLICE-like inhibitory protein (c-FLIP) in ulcerative colitis.
Seidelin JB; Coskun M; Vainer B; Riis L; Soendergaard C; Nielsen OH
J Mol Med (Berl); 2013 Jul; 91(7):839-49. PubMed ID: 23371318
[TBL] [Abstract][Full Text] [Related]
14. RIP-1/c-FLIPL Induce Hepatic Cancer Cell Apoptosis Through Regulating Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL).
Sun J; Yu X; Wang C; Yu C; Li Z; Nie W; Xu X; Miao X; Jin X
Med Sci Monit; 2017 Mar; 23():1190-1199. PubMed ID: 28270653
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of RIP and c-FLIP enhances TRAIL-induced apoptosis in pancreatic cancer cells.
Wang P; Zhang J; Bellail A; Jiang W; Hugh J; Kneteman NM; Hao C
Cell Signal; 2007 Nov; 19(11):2237-46. PubMed ID: 17693058
[TBL] [Abstract][Full Text] [Related]
16. Lipid rafts and nonrafts mediate tumor necrosis factor related apoptosis-inducing ligand induced apoptotic and nonapoptotic signals in non small cell lung carcinoma cells.
Song JH; Tse MC; Bellail A; Phuphanich S; Khuri F; Kneteman NM; Hao C
Cancer Res; 2007 Jul; 67(14):6946-55. PubMed ID: 17638906
[TBL] [Abstract][Full Text] [Related]
17. FLIP-mediated autophagy regulation in cell death control.
Lee JS; Li Q; Lee JY; Lee SH; Jeong JH; Lee HR; Chang H; Zhou FC; Gao SJ; Liang C; Jung JU
Nat Cell Biol; 2009 Nov; 11(11):1355-62. PubMed ID: 19838173
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the ripoptosome and its components: implications for anti-inflammatory and cancer therapy.
Schilling R; Geserick P; Leverkus M
Methods Enzymol; 2014; 545():83-102. PubMed ID: 25065887
[TBL] [Abstract][Full Text] [Related]
19. Autophagy-Mediated Degradation of IAPs and c-FLIP(L) Potentiates Apoptosis Induced by Combination of TRAIL and Chal-24.
Xu J; Xu X; Shi S; Wang Q; Saxton B; He W; Gou X; Jang JH; Nyunoya T; Wang X; Xing C; Zhang L; Lin Y
J Cell Biochem; 2016 May; 117(5):1136-44. PubMed ID: 26448608
[TBL] [Abstract][Full Text] [Related]
20. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M
Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
